EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Beta adrenergic blockade in the treatment of sustained ventricular tachycardia or ventricular fibrillation



Beta adrenergic blockade in the treatment of sustained ventricular tachycardia or ventricular fibrillation



Pacing and Clinical Electrophysiology 19(7): 1026-1035



The value of beta-blockers as antiarrhythmic drugs in patients with sustained VT or VF has received only little attention. This article summarizes the current state of knowledge regarding the identification of patients with sustained VT or VF with the highest benefit of beta-blockade. The antiarrhythmic mechanisms of beta-blockade and its efficacy as single or adjuvant therapy in patients with sustained VT or VF are reviewed. Current insights into the effects of beta-blockade in patients suffering from VT, in particular in the setting of heart failure, are discussed and future directions are considered.

(PDF emailed within 0-6 h: $19.90)

Accession: 045362876

Download citation: RISBibTeXText

PMID: 8823828

DOI: 10.1111/j.1540-8159.1996.tb03409.x



Related references

Induction of ventricular fibrillation during antiarrhythmic drug treatment predicts sudden death in patients with sustained monomorphic ventricular tachycardia or ventricular fibrillation after myocardial infarction. Circulation 90(4 PART 2): I455, 1994

Predictors of mortality in patients with sustained ventricular tachycardias or ventricular fibrillation and depressed left ventricular function: importance of beta-blockade. American Heart Journal 130(2): 281-286, 1995

Recurrent ventricular tachycardia and fibrillation treated with a combination of the beta-adrenergic blockade and electrical pacing. Ann Intern Med 66(5): 945-949, 1967

Recurrent ventricular tachycardia and fibrillation treated with a combination of beta-adrenergic blockade and electrical pacing. Annals of Internal Medicine 66(5): 945-949, 1967

Sex influences the susceptibility to reperfusion-induced sustained ventricular tachycardia and beta-adrenergic receptor blockade in conscious rats. American Journal of Physiology. Heart and Circulatory Physiology 293(5): H2799-H2808, 2007

Effect of beta blockade on ventricular fibrillation- and ventricular tachycardia-induced circulatory arrest in acute myocardial infarction. American Journal of Cardiology 57(12): 34f-37f, 1986

Beta-adrenergic blockade in the treatment of exercise-induced paroxysmal ventricular tachycardia. Circulation 32(5): 778-781, 1965

Specific organized substrates of ventricular fibrillation: comparison of 320-slice CT heart images in non-ischemic ventricular fibrillation subjects with non-ischemic sustained and non-sustained ventricular tachycardia subjects. International Journal of Cardiology 168(2): 1472-1478, 2014

Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillation. British Heart Journal 62(5): 367-371, 1989

The potential beneficial effects of beta adrenergic blockade in the treatment of ventricular fibrillation. European Journal of Pharmacology 616(1-3): 1-6, 2009

Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. Circulation 122(12): 1144-1152, 2010

Inducible sustained ventricular tachycardia and ventricular fibrillation in conscious dogs with isolated right ventricular infarction: relation to infarct structure. Journal of the American College of Cardiology 7(4): 850-858, 1986

Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation. American Journal of Cardiology 71(10): 823-826, 1993

The effect of beta-adrenergic blockade on vulnerability to ventricular fibrillation and inducibility of ventricular arrhythmia in short- and long-term feline infarction models. American Heart Journal 118(2): 265-271, 1989

Induction of ventricular fibrillation, but not of sustained monomorphic ventricular tachycardia predicts sudden death in patients on amiodarone because of ventricular tachyarrhythmias after myocardial infarction. Journal of the American College of Cardiology 0(SPEC ISSUE): 280A, 1994